The raised 2026 guidance and significantly increased 2030 revenue outlook signal accelerating commercial momentum, particularly from Recorlev. Monitor the XP-8121 Phase 3 Cornerstone study initiation by year-end 2026 and topline data expected in late 2028.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $13.08entry
- T+1 · 11d ago +16.21%α +15.90% · $15.20
- T+5 · 5d ago +27.29%α +24.00% · $16.65
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Xeris reported Q3 2026 total revenue of $107.2M, up 44% YoY and above the $101.7M consensus, driven by Recorlev net revenue of $71.5M (+93% YoY). GAAP net income was $11.3M vs $0.6M a year ago. The company raised full-year 2026 revenue guidance to $395M-$405M and raised its 2030 revenue outlook to over $1B, up from approximately $750M.
Key Financial Metrics
Key Facts
- Total revenue $107.2M, up 44% YoY, above consensus of $101.7M
- Recorlev net revenue $71.5M, up 93% YoY
- GAAP net income $11.3M vs $0.6M YoY
- Adjusted EBITDA $30.8M vs $17.4M YoY
- Full-year 2026 revenue guidance raised to $395M-$405M
- 2030 revenue outlook raised to over $1B from approximately $750M
- Gross margin improved to 88% from 85% YoY
- 2028 Convertible Notes fully retired, eliminating ~$34M debt and ~$3M annual interest expense
Financial Impact
Revenue beat of ~$5.5M vs consensus; guidance raised by $10M at midpoint; 2030 outlook increased by >$250M
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Recorlev | $71.5M | +93.0% |
| Gvoke | $21.7M | -14.0% |
| Keveyis | $13.0M | +9.0% |
Risk Factors
- Gvoke revenue declined 14% YoY with a one-time $4M gross-to-net adjustment
- SG&A expenses increased 38% YoY, outpacing revenue growth
- XP-8121 remains in development with no near-term revenue contribution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001867096-26-000114 |
| Document: xers-20261105.htm | 0001867096-26-000114 |
| Document: 0001867096-26-000114-index-headers.html | 0001867096-26-000114 |
| Document: 0001867096-26-000114-index.html | 0001867096-26-000114 |
| Document: 0001867096-26-000114.txt | 0001867096-26-000114 |
| 8-K Data (Synthetic) | 0001867096-26-000114 |
Track record
25 reports on XERS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers